
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Prosus
Market Cap: €98.2b
Engages in the e-commerce and internet businesses in Asia, Europe, Latin America, North America, and internationally.
PRX
€41.98
7D
-0.8%
1Y
-2.5%
Universal Music Group
Market Cap: €32.6b
Operates as a music company worldwide.
UMG
€17.80
7D
-6.3%
1Y
-34.4%
Adyen
Market Cap: €29.3b
Operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America.
ADYEN
€930.40
7D
-3.7%
1Y
-39.7%
Heineken Holding
Market Cap: €18.7b
Engages in brewing and selling beer and cider in the Netherlands, Europe, the Americas, Africa & Middle East, Asia Pacific and internationally.
HEIO
€67.50
7D
-6.1%
1Y
-3.2%
Wolters Kluwer
Market Cap: €15.4b
Provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, Africa, and internationally.
WKL
€68.52
7D
0.5%
1Y
-51.4%
Exor
Market Cap: €14.6b
Engages in the automotive, agriculture and construction, sports car, commercial vehicle, and powertrain businesses worldwide.
EXO
€70.50
7D
-2.5%
1Y
-21.6%
CVC Capital Partners
Market Cap: €12.5b
A private equity and venture capital firm specializing in middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature, recapitalizations, strip sales, and spinouts.
CVC
€11.73
7D
-2.3%
1Y
-36.3%
IMCD
Market Cap: €4.2b
Distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific.
IMCD
€71.72
7D
-7.3%
1Y
-44.3%
Pharming Group
Market Cap: €911.2m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.33
7D
-3.4%
1Y
79.7%
Envipco Holding
Market Cap: €300.1m
Develops, manufactures, assembles, leases, sells, markets, and services a line of reverse vending machines (RVMs) in the Netherlands, the United States, North America, and Europe.
ENVI
€4.54
7D
2.7%
1Y
-13.5%
Avantium
Market Cap: €158.1m
A chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands.
AVTX
€6.27
7D
-5.2%
1Y
-60.5%
Vivoryon Therapeutics
Market Cap: €40.5m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.37
7D
-2.4%
1Y
-28.7%
Cabka
Market Cap: €34.7m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
CABKA
€1.41
7D
-6.3%
1Y
-31.1%